Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
JACC Cardiovasc Interv. 2009 Oct;2(10):934-43. doi: 10.1016/j.jcin.2009.07.013.
The purpose of this study was to evaluate the effectiveness of combined proximal embolic protection with thrombus aspiration (Proxis Embolic Protection System [St. Jude Medical, St. Paul, Minnesota]) in ST-segment elevation myocardial infarction patients.
Embolization during primary percutaneous coronary intervention (PCI) may result in microvascular obstruction, reduced myocardial perfusion, and impaired prognosis.
Two hundred eight-four patients were randomized to primary PCI with the Proxis system versus primary PCI alone after angiography. The primary end point was the occurrence of complete (> or =70%) ST-segment resolution (STR) at 60 min measured by continuous ST-segment Holter.
There was no significant difference in the occurrence of the primary end point (80% vs. 72%, p = 0.14). However, immediate complete STR (at time of last contrast) occurred in 66% of Proxis-treated patients and 50% in control patients (absolute difference, 16.3%; 95% confidence interval: 4.3% to 28.2%; p = 0.009). A significant lower ST-segment curve area (0 to 3 h after primary PCI) was observed in the Proxis arm (5,192 microV/min vs. 6,250 microV/min, p = 0.037). Major adverse cardiac and cerebral events at 30 days occurred with similar frequency in both groups (6 vs. 10).
There was no significant difference in complete STR at 60 min in this proof-of-concept study. However, we observed a significant difference in immediate complete STR in Proxis-treated patients, better STR at later time points, and a reduction of electrocardiogram injury current over time, compared with control patients. The results suggest that primary PCI with the Proxis system may lead to better immediate microvascular flow in ST-segment elevation myocardial infarction patients. (The PREPARE Study; ISRCTN71104460).
本研究旨在评估在 ST 段抬高型心肌梗死患者中,近端联合血栓抽吸栓塞保护(Proxis 栓塞保护系统[圣犹达医疗公司,明尼苏达州圣保罗市])的有效性。
在直接经皮冠状动脉介入治疗(PCI)期间发生的栓塞可能导致微血管阻塞、心肌灌注减少和预后受损。
208 例患者随机分为直接 PCI 联合 Proxis 系统组和单纯直接 PCI 组,根据血管造影结果进行分组。主要终点是通过连续 ST 段 Holter 测量 60 分钟时发生完全(≥70%)ST 段缓解(STR)的情况。
主要终点的发生率无显著差异(80% vs. 72%,p = 0.14)。然而,Proxis 治疗组即刻完全 STR(最后一次对比时)的发生率为 66%,对照组为 50%(绝对差异,16.3%;95%置信区间:4.3%至 28.2%;p = 0.009)。Proxis 组 ST 段曲线面积(直接 PCI 后 0 至 3 小时)显著降低(5192 微伏/分钟 vs. 6250 微伏/分钟,p = 0.037)。两组 30 天内主要心脏和脑不良事件的发生率相似(6 例 vs. 10 例)。
在这项验证概念的研究中,60 分钟时完全 STR 无显著差异。然而,我们观察到 Proxis 治疗组即刻完全 STR 有显著差异,晚期 STR 更好,心电图损伤电流随时间减少,与对照组相比。这些结果表明,在 ST 段抬高型心肌梗死患者中,直接 PCI 联合 Proxis 系统可能会导致更好的即刻微血管血流。(PREPARE 研究;ISRCTN71104460)。